Issues in antiretroviral toxicity.
Boyle
Brian A
BA
Department of International Medicine and Infectious Disease, New York Presbyterian Hospital-Weill Medical College, Cornell University, New York, USA.
D000480:Alkynes; D019380:Anti-HIV Agents / Q000009:adverse effects*; D048588:Benzoxazines; D018791:CD4 Lymphocyte Count; D003521:Cyclopropanes; D005076:Exanthema / Q000139:chemically induced; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D039682:HIV-Associated Lipodystrophy Syndrome / Q000209:etiology*; D006801:Humans; D008297:Male; D019829:Nevirapine / Q000009:adverse effects*; D010078:Oxazines / Q000009:adverse effects*; D011247:Pregnancy; D011788:Quality of Life; D016032:Randomized Controlled Trials as Topic
D000480:Alkynes; D019380:Anti-HIV Agents; D048588:Benzoxazines; D003521:Cyclopropanes; D010078:Oxazines; D019829:Nevirapine; C098320:efavirenz